Nephrocare Subsidiary Acquires Dialysis Center Assets in Philippines for PhP 71.8 Million

Nephrocare Subsidiary Acquires Dialysis Center Assets in Philippines for PhP 71.8 Million

Nephrocare Subsidiary Acquires Dialysis Center Assets in Philippines for PhP 71.8 Million​

Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, has acquired identified assets relating to a dialysis center located in Davao City, Philippines. The acquisition was completed through an Asset Transfer Agreement dated August 12, 2026.

The transaction involved the purchase of these specific assets from Juan Nephro Dialysis Center for a total consideration of PhP 71,800,000 (Philippine Pesos Seventy-One Million Eight Hundred Thousand Pesos Only).

The details of the acquisition and both parties are summarized below:

ParticularsDetail
PurchaserNephrocare Health Care Services, Philippines Inc.
SellerJuan Nephro Dialysis Center
Transaction PurposeAcquisition of identified assets relating to a dialysis center in Davao City, Philippines.
Agreement SizePhP 71,800,000

Nephrocare Health Care Services, Philippines Inc., acts as the purchaser in the transaction. The Seller, Juan Nephro Dialysis Center, was determined not to be related to the company.

According to the terms of the agreement, there are no special rights granted by either party and the transaction does not fall under the category of a related party transaction.

NEPHROPLUS Stock Price Movement​

Today, shares of Nephrocare Health Services Limited edged higher in the session, concluding at ₹689.00 after gaining 1.45%. The stock traded within a tight range for the day, moving between a low of ₹675 and a high of ₹689.4 on a volume of 32,020 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Editorial Note

This news article was written and created by Deepali, and published on IST.
Back
Top